Invivogen corp:1107099 [18-051071]
Ended Purchase Order Awarded Last action
- Contract number
- 75N91018P00526
- Awardee
-
Invivoscribe, Inc. UEI R1EVMK8MEZS9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,090
Award facts
- Contract value 100% obligated
- $9,090.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Invivoscribe, Inc. for $9,090 on July 18, 2018, with an ultimate completion date of July 18, 2019. Work is performed in San Diego, California. The order is priced on a firm fixed price basis for biological kits, reagents, and assays supporting the Molecular Diagnostics Laboratory's cancer research and diagnostics operations.
Quick answers
Who was awarded contract 75N91018P00526?
75N91018P00526 was awarded to Invivoscribe, Inc. by National Cancer Institute (National Institutes of Health) on July 18, 2018.
How much is contract 75N91018P00526 worth?
The government has obligated $9,090 on 75N91018P00526.
Was contract 75N91018P00526 competed?
The extent of competition for 75N91018P00526 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award